GlassScriptPhysician profile
Kenneth Lyle Crump
NPI 1891719308
$5,351.28
in general payments reported to CMS, 2019-2025
51 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $560 · 2021: $2,020 · 2022: $1,024 · 2023: $595 · 2024: $327 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,394.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,252.52 | 2021 | |
| Abbvie INC. | $1,148.96 | 2019-2025 | Qulipta, Ubrelvy, Vraylar |
| Lilly USA, LLC | $240.93 | 2019-2025 | Jardiance, Mounjaro |
| Merck Sharp & Dohme LLC | $198.05 | 2020-2023 | Belsomra, Steglatro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $180.92 | 2019-2023 | Trijardy Xr, Synjardy |
| Amgen INC. | $167.77 | 2020-2025 | Evenity, Repatha, Prolia |
| Amarin Pharma, INC. | $163.01 | 2019-2020 | |
| Pfizer INC. | $141.49 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $133.08 | 2019-2024 | Airsupra |
| Janssen Pharmaceuticals, INC | $117.85 | 2020-2023 | Spravato |
| Boston Scientific Corporation | $117.21 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Supernus Pharmaceuticals, INC. | $111.81 | 2019-2024 | Qelbree |
| Novo Nordisk INC | $91.62 | 2019-2024 | Wegovy |
| Exact Sciences Corporation | $90.61 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Emd Serono, INC. | $84.59 | 2019-2025 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Crump listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.